Latest Breaking News On - Eyepoint pharmaceuticals price performance - Page 1 : vimarsana.com

Analysts Set EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Target Price at $34 00

Analysts Set EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Target Price at $34 00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Securities exchange commissionHermes incInsider activity at eyepoint pharmaceuticalsEyepoint pharmaceuticals incFranklin resources incAnalyst recommendations for eyepoint pharmaceuticalsEyepoint pharmaceuticals price performanceNews ratings for eyepoint pharmaceuticals dailyJennison associatesJpmorgan chase coEyepoint pharmaceuticals company profileVanguard group incInstitutional investors weigh in on eyepoint pharmaceuticalsEyepoint pharmaceuticalsGet free reportOne financial

EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Given Consensus Recommendation of Buy by Analysts

EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Given Consensus Recommendation of Buy by Analysts
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdChina universal asset management coEyepoint pharmaceuticalsNews ratings for eyepoint pharmaceuticals dailyJpmorgan chase coEyepoint pharmaceuticals incTower research capitalAnalyst recommendations for eyepoint pharmaceuticalsSherbrooke park advisersInvestment advisersEyepoint pharmaceuticals price performanceToth financial advisory corpGet free reportOne financialCormorant asset managementUniversal asset management

EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Major Shareholder Cormorant Asset Management, Lp Buys 850,000 Shares of Stock

EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Major Shareholder Cormorant Asset Management, Lp Buys 850,000 Shares of Stock
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdInvestment advisersNews ratings for eyepoint pharmaceuticals dailyEyepoint pharmaceuticals price performanceSecurities exchange commissionInstitutional investors weigh in on eyepoint pharmaceuticalsProshare advisorsToth financial advisory corpTower research capitalEyepoint pharmaceuticals incChina universal asset management coEyepoint pharmaceuticals company profileQuarter for eyepoint pharmaceuticalsJpmorgan chase coEyepoint pharmaceuticalsGet free report

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down to $19 74

Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $19.74, but opened at $13.89. EyePoint Pharmaceuticals shares last traded at $12.99, with a volume of 4,364,816 shares traded. Analyst Upgrades and Downgrades A number of equities research analysts have […]

Securities exchange commissionCapstone investment advisorsEyepoint pharmaceuticalsEyepoint pharmaceuticals price performanceEssex investment management coNews ratings for eyepoint pharmaceuticals dailyChina universal asset management coEyepoint pharmaceuticals incWoodstock corpJpmorgan chase coHedge funds weigh in on eyepoint pharmaceuticalsJanney montgomery scottGet free reportPoint pharmaceuticalsOne financialCormorant asset management

Cormorant Asset Management, Lp Acquires 581,765 Shares of EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Stock

Cormorant Asset Management, Lp Acquires 581,765 Shares of EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China universal asset management coSecurities exchange commissionQuarter for eyepoint pharmaceuticalsJpmorgan chase coEyepoint pharmaceuticals incNews ratings for eyepoint pharmaceuticals dailySherbrooke park advisersEyepoint pharmaceuticals price performanceTower research capitalEyepoint pharmaceuticalsInvestment advisersHedge funds weigh in on eyepoint pharmaceuticalsToth financial advisory corpGet free reportCormorant asset managementExchange commission